SCREENING AFTER STROKE - ATRIAL FIBRILLATION
Recruiting
Observational Study
Atrial Fibrillation (AF)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 410 (estimated)
- Sponsor
- Vestre Viken Hospital Trust · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
As much as 20-30% of all strokes are attributed to atrial fibrillation (AF), making the detection of AF highly important, as AF-related strokes are largely preventable with optimal treatment. Therefore, most guidelines recommend screening patients for AF after a stroke, although the optimal timing and choice of monitoring device for screening remain undefined. Our aim is to investigate whether AF …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years or older
* Ischemic stroke
* Without known AF or those with previously diagnosed paroxysmal AF exhibiting sinus rhythm upon admission
Exclusion Criteria:
* AF at hosptial admission
* Unable or unwilling to provide informed consent
* A life expectancy of less than on…
Contacts